Sequoia Financial Advisors, LLC Eli Lilly & CO Transaction History

Sequoia Financial Advisors, LLC

$8.93 Billion
Q3 2024

A detailed history of Sequoia Financial Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Sequoia Financial Advisors, LLC holds 68,490 shares of LLY stock, worth $53.4 Million. This represents 0.68% of its overall portfolio holdings.

Number of Shares

68,490

Previous 62,421 9.72%

Holding current value

$53.4 Million

Previous $56.5 Million 7.37%

% of portfolio

0.68%

Previous 0.7%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	BUY	$772.14 - $960.02 $4.69 Million - $5.83 Million	6,069 Added 9.72%	68,490 $60.7 Million
Q2 2024 Jul 15, 2024	BUY	$724.87 - $909.04 $5.54 Million - $6.94 Million	7,636 Added 13.94%	62,421 $56.5 Million
Q1 2024 Apr 30, 2024	SELL	$592.2 - $792.28 $5.65 Million - $7.56 Million	-9,538 Reduced 14.83%	54,785 $42.6 Million
Q4 2023 Jan 25, 2024	BUY	$525.19 - $619.13 $26.5 Million - $31.2 Million	50,378 Added 361.26%	64,323 $37.5 Million
Q3 2023 Nov 08, 2023	SELL	$434.7 - $599.3 $119,977 - $165,406	-276 Reduced 1.94%	13,945 $7.49 Million
Q2 2023 Aug 08, 2023	BUY	$350.74 - $468.98 $244,465 - $326,879	697 Added 5.15%	14,221 $6.67 Million
Q1 2023 Apr 24, 2023	BUY	$310.63 - $364.82 $154,693 - $181,680	498 Added 3.82%	13,524 $4.64 Million
Q4 2022 Feb 10, 2023	SELL	$321.55 - $374.67 $43,730 - $50,955	-136 Reduced 1.03%	13,026 $4.77 Million
Q4 2022 Jan 17, 2023	BUY	$321.55 - $374.67 $2.32 Million - $2.7 Million	7,209 Added 121.1%	13,162 $0
Q3 2022 Oct 26, 2022	SELL	$296.48 - $337.87 $192,119 - $218,939	-648 Reduced 9.82%	5,953 $1.93 Million
Q2 2022 Jul 22, 2022	SELL	$278.73 - $327.27 $513,420 - $602,831	-1,842 Reduced 21.82%	6,601 $2.14 Million
Q1 2022 May 13, 2022	BUY	$234.69 - $291.66 $359,310 - $446,531	1,531 Added 22.15%	8,443 $2.42 Million
Q4 2021 Feb 11, 2022	BUY	$224.85 - $279.04 $998,334 - $1.24 Million	4,440 Added 179.61%	6,912 $1.91 Million
Q3 2021 Oct 26, 2021	SELL	$221.6 - $272.71 $767,622 - $944,667	-3,464 Reduced 58.36%	2,472 $571,000
Q2 2021 Jul 27, 2021	BUY	$180.55 - $233.54 $80,886 - $104,625	448 Added 8.16%	5,936 $1.36 Million
Q1 2021 May 14, 2021	BUY	$164.32 - $212.72 $9,201 - $11,912	56 Added 1.03%	5,488 $1.03 Million
Q4 2020 Feb 12, 2021	BUY	$130.46 - $172.63 $74,753 - $98,916	573 Added 11.79%	5,432 $917,000
Q3 2020 Oct 23, 2020	BUY	$146.22 - $169.13 $11,990 - $13,868	82 Added 1.72%	4,859 $719,000
Q2 2020 Aug 25, 2020	BUY	$136.42 - $164.18 $651,678 - $784,287	4,777 New	4,777 $784,000
Q2 2020 Aug 11, 2020	SELL	$136.42 - $164.18 $713,749 - $858,989	-5,232 Closed	0 $784,000
Q1 2020 May 11, 2020	BUY	$119.05 - $147.35 $159,884 - $197,891	1,343 Added 34.53%	5,232 $726,000
Q4 2019 Feb 13, 2020	BUY	$106.92 - $132.43 $57,950 - $71,777	542 Added 16.19%	3,889 $511,000
Q3 2019 Oct 22, 2019	BUY	$106.79 - $116.16 $26,804 - $29,156	251 Added 8.11%	3,347 $374,000
Q2 2019 Jul 31, 2019	SELL	$110.79 - $129.32 $21,714 - $25,346	-196 Reduced 5.95%	3,096 $343,000
Q1 2019 May 13, 2019	BUY	$111.31 - $131.02 $11,910 - $14,019	107 Added 3.36%	3,292 $427,000
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $105 - $118	1 Added 0.03%	3,185 $369,000
Q3 2018 Nov 14, 2018	SELL	$85.86 - $107.31 $34,601 - $43,245	-403 Reduced 11.24%	3,184 $342,000
Q2 2018 Aug 14, 2018	BUY	$75.7 - $86.88 $23,845 - $27,367	315 Added 9.63%	3,587 $306,000
Q1 2018 May 14, 2018	BUY	$74.21 - $87.6 $39,702 - $46,866	535 Added 19.55%	3,272 $253,000
Q4 2017 Feb 13, 2018	BUY	$81.94 - $87.89 $29,990 - $32,167	366 Added 15.44%	2,737 $231,000
Q3 2017 Nov 13, 2017	BUY	$77.07 - $85.54 $182,732 - $202,815	2,371	2,371 $203,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $740B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sequoia Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sequoia Financial Advisors, LLC with notifications on news.

Account

Sequoia Financial Advisors, LLC Eli Lilly & CO Transaction History